These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8296454)

  • 21. Anti-haemolysin IgG1 to IgG2 ratios correlate with haemolysin neutralization titres and lung lesion scores in Actinobacillus pleuropneumoniae infected pigs.
    Furesz SE; Wilkie BN; Mallard BA; Rosendal S; MacInnes JI
    Vaccine; 1998 Dec; 16(20):1971-5. PubMed ID: 9796052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic differences within Actinobacillus pleuropneumoniae serotype 1.
    Jolie RA; Mulks MH; Thacker BJ
    Vet Microbiol; 1994 Feb; 38(4):329-49. PubMed ID: 8160348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AasP autotransporter protein of Actinobacillus pleuropneumoniae does not protect pigs against homologous challenge.
    Oldfield NJ; Worrall KE; Rycroft AN; Ali T; Wooldridge KG; Ala'Aldeen DA
    Vaccine; 2009 Aug; 27(38):5278-83. PubMed ID: 19563888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.
    Hensel A; Huter V; Katinger A; Raza P; Strnistschie C; Roesler U; Brand E; Lubitz W
    Vaccine; 2000 Jul; 18(26):2945-55. PubMed ID: 10825595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.
    Zhang F; Zhao Q; Quan K; Zhu Z; Yang Y; Wen X; Chang YF; Huang X; Wu R; Wen Y; Yan Q; Huang Y; Ma X; Han X; Cao S
    PLoS One; 2018; 13(6):e0198207. PubMed ID: 29856812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
    Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S
    Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines.
    Inzana TJ; Todd J; Veit HP
    Infect Immun; 1993 May; 61(5):1682-6. PubMed ID: 8478056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of serotype-specific vaccine candidate genes in Actinobacillus pleuropneumoniae and heterologous immunization with Propionibacterium acnes.
    Lei L; Sun C; Lu S; Feng X; Wang J; Han W
    Vaccine; 2008 Nov; 26(49):6274-80. PubMed ID: 18835316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of different doses of antigen for intradermal administration in pigs: the Actinobacillus pleuropneumoniae model.
    Bernardy J; Nechvatalova K; Krejci J; Kudlacková H; Brazdova I; Kucerova Z; Faldyna M
    Vaccine; 2008 Nov; 26(50):6368-72. PubMed ID: 18824203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The live attenuated Actinobacillus pleuropneumoniae triple-deletion mutant ΔapxIC ΔapxIIC ΔapxIV-ORF1 strain, SLW05, Immunizes pigs against lethal challenge with Haemophilus parasuis.
    Fu S; Ou J; Zhang M; Xu J; Liu H; Liu J; Yuan F; Chen H; Bei W
    Clin Vaccine Immunol; 2013 Feb; 20(2):134-9. PubMed ID: 23220998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aerosol exposure of pigs to viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces antibodies in bronchoalveolar lining fluids and serum, and protects against homologous challenge.
    Hensel A; Stockhofe-Zurwieden N; Ganter M; Petzoldt K
    Vet Microbiol; 1995 Nov; 47(1-2):27-41. PubMed ID: 8604553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral antibody response and protective immunity in swine following immunization with the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae.
    Devenish J; Rosendal S; Bossé JT
    Infect Immun; 1990 Dec; 58(12):3829-32. PubMed ID: 2254012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of the combined vaccine prepared from cell-free-antigen of Actinobacillus pleuropneumoniae serotypes 1, 2 and 5 in pigs.
    Oishi E; Kitajima T; Koyama Y; Ohgitani T; Katayama S; Okabe T
    J Vet Med Sci; 1995 Dec; 57(6):1125-8. PubMed ID: 8720063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies.
    Ramjeet M; Deslandes V; Gouré J; Jacques M
    Anim Health Res Rev; 2008 Jun; 9(1):25-45. PubMed ID: 18346296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-protection experiments in pigs vaccinated with Actinobacillus pleuropneumoniae subtypes 1A and 1B.
    Jolie RA; Mulks MH; Thacker BJ
    Vet Microbiol; 1995 Aug; 45(4):383-91. PubMed ID: 7483251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae.
    Nielsen R; van den Bosch JF; Plambeck T; Sørensen V; Nielsen JP
    Vet Microbiol; 2000 Jan; 71(1-2):81-7. PubMed ID: 10665536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs.
    Bei W; He Q; Zhou R; Yan L; Huang H; Chen H
    Vet Microbiol; 2007 Nov; 125(1-2):120-7. PubMed ID: 17580102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model.
    Chiang CH; Huang WF; Huang LP; Lin SF; Yang WJ
    Vaccine; 2009 Jul; 27(34):4565-70. PubMed ID: 19520199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.
    Loera-Muro A; Angulo C
    Vet Microbiol; 2018 Apr; 217():66-75. PubMed ID: 29615259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
    van den Bosch H; Frey J
    Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.